Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Feb 19;256(3):249–257. doi: 10.1016/j.taap.2011.02.003

Fig. 3. Concentrations of Cu in serum, CSF, and brain parenchyma by ICP-MS analysis.

Fig. 3

Fig. 3

Animal treatment is described in the legend to Fig. 1. (A) Cu levels in serum. (B) Cu levels in CSF. (C) Cu levels in brain parenchyma. Data represent mean ± S.D., n=5-6. **=p<0.01; *=p<0.05.